Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Electropharmacology, Inc. (OTC BB:EPHI.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: News | Profile
Recent Events
Aug 22Price hit new 52-week low ($0.001)
Location
PMB 191, 2342 Shattuck Avenue
Berkeley, CA 94704
Phone: (510) 666-1214
Email: support@geno-mechanix.com
Financial Links
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 60%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Electropharmacology, Inc. previously created novel products for the improved treatment of complex human diseases such as cancer, wounds, chronic infections, inflammation and tissue degeneration associated with aging or autoimmune disorders. The Company's primary focus was on products for diseases that affect superficial tissues such as skin, breasts, brain, prostate and joints. On March 23, 2001, the Company announced that due to the cancellation of the license with Elan Corporation and its subsidiaries' inability to satisfy past operating debt, service long-term debt, fund current and future operating expenses, the Company suspended operations, laid off most of the its staff, and began to explore options to sell its assets.
More from Market Guide: Expanded Business Description

Financial Summary
EPHI suspended operations and is exploring the sale of its assets. EPHI developed, manufactured and marketed medical devices that deliver pulsed electromagnetic signals in the radio frequency range. For the fiscal year ended 12/31/00, revenues fell 23% to $396 thousand. Net loss applicable to common fell 21% to $2.3 million. Revenues suffered from decreased product sales and the relocation of the Gemini operations. Net loss reflects a decreased loss on the sale of securities.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

Arup Sen, Ph.D., 48
Chairman, Pres, CEO, Chief Financial Officer, Sec.
$331K
Richard Kneipper, 56
Vice Chairman
--  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:EPHI.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Aug-2001
$0.001
Recent Price$0.01 
52-Week High
on 7-Sep-2000
$0.281
Beta-0.12 
Daily Volume (3-month avg)2,955 
Daily Volume (10-day avg)0 
Stock Performance
52-Week Change-94.2%
52-Week Change
relative to S&P500
-92.2%
Share-Related Items
Market Capitalization$178.0K
Shares Outstanding17.8M
Float7.10M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)-$0.71 
Earnings (ttm)-$0.13 
Earnings (mrq)-$0.03 
Sales (ttm)$0.02 
Cash (mrq)0 
Valuation Ratios
Price/BookN/A 
Price/EarningsN/A 
Price/Sales (ttm)0.44 
Income Statements
Sales (ttm)$396.0K
EBITDA (ttm)-$1.08M
Income available to common (ttm)-$2.26M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter31-Dec-2000
Management Effectiveness
Return on Assets (ttm)-337.86%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.00 
Debt/EquityN/A 
Total Cash (mrq)$4,000 
Short Interest
As of 8-Sep-1997
Shares Short12.0K
Percent of Float4.0%
Shares Short
(Prior Month)
3,000 
Short Ratio1.00 
Daily Volume12.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Dec-2000)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.